High-throughput single-cell sorting and kinetic analysis of secreted particles

Information

  • Research Project
  • 9748829
  • ApplicationId
    9748829
  • Core Project Number
    R44GM128223
  • Full Project Number
    3R44GM128223-03S1
  • Serial Number
    128223
  • FOA Number
    PA-18-591
  • Sub Project Id
  • Project Start Date
    9/1/2015 - 9 years ago
  • Project End Date
    8/31/2019 - 5 years ago
  • Program Officer Name
    SAMMAK, PAUL J
  • Budget Start Date
    9/1/2018 - 6 years ago
  • Budget End Date
    8/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    03
  • Suffix
    S1
  • Award Notice Date
    9/13/2018 - 6 years ago

High-throughput single-cell sorting and kinetic analysis of secreted particles

High-throughput single-cell sorting and kinetic analysis of secreted particles NanoCellect Biomedical, Inc. RESEARCH & RELATED Other Project Information 7. PROJECT SUMMARY Advances in reagents and analytical tools have improved characterization of cellular phenotypes. However, most studies are still performed on cell populations that are morphologically and genetically homogeneous, yet have important biological heterogeneity; with individual cells having unique phenotypic or `omic profiles. This leads to an average measurement of individual cells, none of which may actually be average. Single-cell analysis can define the scope of cell-to-cell variations within a population and provide in-depth analysis of single, exceptional cells in contexts such as stem cell differentiation or cancer, where these cells can give rise to clonal populations that drive the biology. While novel tools such as multiparameter flow cytometry, mass cytometry, and image-based cytometry provide in-depth analysis of individual cells, these technologies only provide a single time point ?snapshot? and lack downstream molecular analysis. This project will develop for commercialization an integrated cell-sorting, cell dispensing, and single-cell positioning device to allow single cells to be tracked and measured over time. In addition, we will demonstrate a commercial prototype device that allows transfer of individual cells with desired phenotypic characteristics to 1536-well plates for downstream analysis in a standard format. This integrated system will be benchmarked with cells derived from glioblastoma that has been shown to have important exosome biological characteristics.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    72000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:72000\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NANOCELLECT BIOMEDICAL, INC.
  • Organization Department
  • Organization DUNS
    832751098
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921221937
  • Organization District
    UNITED STATES